Article Versions Notes

Tran D, Ishaq M, Yang C, Ahmad T, Ronci M, Zuccarini M, Myers S, McGowan C, Eri R, Henstridge DC, et al. Twelve Weeks of Oral L-Serine Supplementation Improves Glucose Tolerance, Reduces Visceral Fat Pads, and Reverses the mRNA Overexpression of Renal Injury Markers KIM-1, IL-6, and TNF-α in a Mouse Model of Obesity. Nutraceuticals. 2023; 3(2):262-273. https://doi.org/10.3390/nutraceuticals3020021

Tran, Duyen, Muhammad Ishaq, Cheng Yang, Tauseef Ahmad, Maurizio Ronci, Mariachiara Zuccarini, Stephen Myers, Courtney McGowan, Rajaraman Eri, Darren C. Henstridge, and et al. 2023. "Twelve Weeks of Oral L-Serine Supplementation Improves Glucose Tolerance, Reduces Visceral Fat Pads, and Reverses the mRNA Overexpression of Renal Injury Markers KIM-1, IL-6, and TNF-α in a Mouse Model of Obesity" Nutraceuticals 3, no. 2: 262-273. https://doi.org/10.3390/nutraceuticals3020021

Tran, D., Ishaq, M., Yang, C., Ahmad, T., Ronci, M., Zuccarini, M., Myers, S., McGowan, C., Eri, R., Henstridge, D. C., Sonda, S., & Caruso, V. (2023). Twelve Weeks of Oral L-Serine Supplementation Improves Glucose Tolerance, Reduces Visceral Fat Pads, and Reverses the mRNA Overexpression of Renal Injury Markers KIM-1, IL-6, and TNF-α in a Mouse Model of Obesity. Nutraceuticals, 3(2), 262-273. https://doi.org/10.3390/nutraceuticals3020021